CLINICAL ENDOCRINOLOGY, cilt.39, ss.151-155, 1993 (SCI İndekslerine Giren Dergi)
OBJECTIVE We determined the 17-hydroxyprogesterone (17-OH P) response to buserelin, a GnRH agonist, and its relation to ovarian volume in the patients with polycystic ovary syndrome (PCOS).